Title: Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
Journal: Journal of medicinal chemistry 20110623
151427-13-3
7644-04-4
99-90-1
61858-39-7
69374-79-4
46258-62-2
27058-83-9 | 2-Amino-4-chlorobenzothiazole hydrobromide | AA003GCA | MFCD00035186
77326-62-6 | 2-Amino-6-bromobenzonitrile | AA003GF7 | MFCD09834769
52200-49-4 | 2-(Benzyloxy)-3-bromopyridine | AA003GII | MFCD09037467
71189-13-4 | 2-bromo-1-isocyanato-4-methylbenzene | AA003GLW | MFCD03701593
53882-80-7 | 2-Bromobenzoylacetonitrile | AA003GOV | MFCD02260798
881891-82-3 | 2-Chloro-3-fluoro-4-methylpyridine | AA003GSL | MFCD04112510
80945-82-0 | 2-Chloro-5-benzothiazolamine | AA003GVL | MFCD11040282
766-66-5 | 2-Chlorocycloheptanone | AA003GZB | MFCD00041033
66799-97-1 | 2-Ethoxy-3-methoxybenzaldehyde | AA003H36 | MFCD00016584
1427-07-2 | 2-fluoro-1-methyl-4-nitrobenzene | AA003H6Z | MFCD00007199